A research group from the National Cancer Research Centre (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult.
Read moreThe center is participating in an international clinical trial that seeks to improve patients' quality of life by addressing sleep, communication and motor disorders.
Read moreA study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates how a CAR-T therapy designed at the center c...
Read moreFBS provides the complex mixture of biomolecules necessary to support cell attachment, proliferation, and viability. Unlike defined synthetic alternatives, it offers a broad spectrum of macromolecules...
Read moreCada 22 de septiembre se conmemora el Día Mundial de la Leucemia Mieloide Crónica, una fecha clave para visibilizar la enfermedad y destacar la importancia de la investigación, la detección precoz...
Read moreIn the complex world of pharmaceutical and biotechnology drug development, PIVOTAL serves as your trusted medical partner – delivering expert medical oversight and strategic insight across every pha...
Read moreLas terapias avanzadas representan una transformación profunda en la forma de abordar enfermedades complejas, crónicas o sin cura. Basadas en la genética, la biología celular y la ingeniería d...
Read moreLa Fundación ”la Caixa” ha seleccionado dos proyectos del Cima Universidad de Navarra dentro de la convocatoria 2025 del programa CaixaImpulse, iniciativa que financia propuestas biomédicas nove...
Read moreUn equipo investigador del Hospital de Bellvitge, el IDIBELL, la Universitat de Barcelona (UB) y el CIBERDEM ha descubierto que el uso crónico de la glibenclamida, un fármaco de la familia de las su...
Read moreA study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilise nearly all mutate...
Read moreAt 53Biologics, they see CQAs as the blueprint of product quality. By identifying them early and controlling them consistently, biotech companies can navigate development more smoothly, avoid costly d...
Read moreResearch grade recombinant protein expands toolkit of available CRISPR nucleases and increases efficiency of homology-directed repair (HDR) to enable more precise genome modifications
Read more